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This article provides an overview of the 
current methods of diagnosis and treat-
ment of patients with vertigo, dizziness, or 
imbalance, as well as an analysis of ongo-
ing problems besetting the field of neu-
ro-otology. Aims and challenges are also 
described with the hope of stimulating basic 
and clinical research on these very frequent 
symptoms.
Vertigo and dizziness are among the 
most frequent symptoms that patients 
 experience at some time in their lives. With 
a lifetime prevalence of about 30% and an 
annual incidence that increases with age, 
vertigo and dizziness will become even 
more important in the future. Despite this 
high prevalence and burden of disease, con-
siderable challenges remain.
•	 Most	 patients	 with	 acute	 vertigo	 and	
dizziness are uncertain who to consult, 
because their problem lies inbetween 
the specializations of ear, nose, and 
throat (ENT) and neurology, and in 
some cases, ophthalmology, internal 
medicine, or psychiatry.
•	 While	neurologists	are	very	familiar	with	
the anatomy, physiology, and pathophy-
siology of the central nervous system 
(central vestibular and ocular motor 
systems), ENT physicians specialize in 
the peripheral vestibular and audiolo-
gical systems. However, very few have 
detailed knowledge of both the central 
and	peripheral	systems.	Moreover,	most	
ENT physicians practice mainly as ENT 
surgeons, and therefore, they are not 
necessarily specialists on vertigo and 
dizziness.
•	 With	 a	 few	 exceptions	 (South	 Korea,	
and	some	centers	in	the	USA,	UK,	and	
Australia) cooperation between neuro-
logy and ENT as well as neuro-otology 
and oto-neurology is far from perfect. 
The underlying diseases resulting in ver-
tigo and dizziness cover a broad spec-
trum of anatomical structures. Possible 
etiologies include ischemia, infection, 
autoimmune disorders, mechanical 
inner ear disorders, psychosomatic, 
and somatoform disorders. Therefore, 
the approach to patients requires a 
broad-based knowledge of anatomy, 
physiology, pathophysiology, and phar-
macology as well as in-depth practical 
experience with the different methods 
available for evaluating the vestibular 
and ocular motor systems.
•	 Medical	 education	 in	 neuro-otology	
is also less than optimal. The problem 
begins	 in	 Medical	 School,	 where	 the	
vestibular and ocular motor systems are 
assumed to be among the most complica-
ted anatomical and physiological systems 
of humans. Therefore, most medical stu-
dents are not attracted to this field, which 
may also explain their limited knowledge 
of the subject. This downward trend 
continues during post-graduate training 
for most neurologists and ENT physi-
cians, and is further exacerbated by the 
above-mentioned overlapping of the two 
disciplines.	Moreover,	to	establish	a	cor-
rect diagnosis, physicians must examine 
the vestibular, audiological, and ocu-
lar motor systems. Furthermore, many 
physicians have difficulties examining 
the ocular motor system and ultima-
tely interpreting their findings. What is 
pathological and what do the findings 
mean? Thus, topographical anatomical 
diagnosis remains a challenge: it is impe-
rative to be able to discriminate between 
peripheral and central vestibular lesions 
is imperative.
•	 The	link	between	basic	physiology	and	
the modeling of the vestibular and the 
ocular motor systems, on the one hand, 
and their clinical implications and 
applications, on the other, are far from 
ideal. While we know the detailed wor-
kings of the vestibular and ocular motor 
systems and can model their function 
and dysfunction, this knowledge has 
not yet been fully integrated in clinical 
practice. Conversely, clinical findings 
have to be linked with basic knowledge 
in order to stimulate the knowledge of 
physiology and the modeling of these 
systems.
•	 State-of-the-art	randomized	controlled	
clinical trials on the frequent causes of 
vertigo and dizziness as well as their 
underlying disorders are still lacking. 
This is true for phobic postural vertigo, 
vestibular	migraine,	Menière’s	 disease,	
vestibular paroxysmia, downbeat and 
upbeat nystagmus, episodic ataxia, and 
perilymphatic fistula.
•	 The	 number	 of	 studies	 available	 on	
the impact of vertigo and dizziness, as 
well as impaired vestibular function on 
patients’	quality	of	life	and	functioning	
are limited.
•	 Long-term	 studies	 on	 the	 natural	
course of the different forms of vertigo, 
their recurrence rates, or the long-term 
efficacy of available treatments are non-
existent. This is true for most forms of 
vertigo and dizziness.
In brief our growing knowledge of the 
anatomy and physiology of the vestibular 
and related ocular motor systems, as well 
as basic and clinical research must still 
overcome a number of shortcomings and 
limitations to improve diagnosis, develop 
new diagnostic criteria, and better under-
stand the pathophysiology of these disor-
ders. Hopefully, new treatment strategies 
and state-of-the-art prospective clinical 
trials will improve the quality of life and 
functioning in patients with vertigo and 
dizziness.
How can we solve tHese 
worldwide problems?
First, we must increase worldwide awareness 
of the impact of vertigo and dizziness. While 
acute vertigo and dizziness may be the first 
sign of severe neurological disorders such 
as brainstem or cerebellar ischemia, chronic 
vertigo, dizziness, and balance disorders – in 
particular, if patients are not aware of their 
cause and are not adequately treated – have 
a considerable socio-economic impact.
Second,	it	is	very	important	to	improve	
the cooperation between ENT, neurology, 
neuro-ophthalmology, ophthalmology, 
and psychiatry, because many patients fall 
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vestibulopathy,	Menière’s	disease,	downbeat	
nystagmus, and episodic ataxia, to further 
enhance our knowledge about the histologi-
cal changes and to differentiate possibly dif-
ferent forms. Finally, vestibular prostheses are 
being developed for patients with a complete 
bilat eral vestibular failure but they still have 
to be implemented in clinical use.
The long-term goals of these measures 
should be
1. to improve our knowledge of the patho-
logical anatomy and pathophysiology 
of the different causes of vertigo and 
dizziness arising from the labyrinth, 
vestibular nerve, brainstem, and cere-
bellum. Based on this knowledge, new 
therapeutic paradigms can be deve-
loped, particularly to improve central 
vestibular compensation after periphe-
ral and central vestibular lesions.
2. to define worldwide accepted diagno-
stic criteria for the different causes of 
vertigo and dizziness, which can also 
form the basis for future clinical trials.
3. to improve the quality of life and 
functioning of these patients with 
physiotherapy, pharmacotherapy, psy-
chotherapy, or surgery after correct 
diagnoses have been made and specific 
therapies established.
Looking	back	at	the	developments	in	the	
field over the last 20 years, we are highly 
optimistic that most of these goals will be 
reached within the next 20 years.
Submission	of	manuscripts	dealing	with	
the above-mentioned aspects will be very 
welcomed at Frontiers in Neuro-otology.
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•	 Menière’s	disease	–	 there	 is	 still	 a	ple-
thora of recommended treatments for 
this disorder, including a salt-free diet, 
diuretics, aminoglycosides, corticoste-
roids, betahistine, change of pressure in 
the middle ear, and surgery.
•	 Vestibular	neuritis	–	the	potential	effi-
cacy of corticosteroids and physiothe-
rapy must still be determined.
•	 Vestibular	migraine	–	 the	acute	effects	
of drugs (also used in the treatment 
of migraine with or without aura), as 
well as the prophylactic treatment with 
beta-blockers, topiramate, or valproic 
acid must be investigated.
•	 Perilymphatic	 fistula	 –	 the	 natural	
course of this disorder should be com-
pared with canal plugging, canal resur-
facing, as well as fixation of the stapes.
•	 Bilateral	 vestibulopathy	 –	 the	 efficacy	
of physiotherapy and possible efficacy 
of certain drugs to improve the gain 
of the vestibulo-ocular reflex must be 
evaluated.
•	 Vestibular	paroxysmia	–	treatment	with	
agents such as carbamazepine or oxcar-
bamazepine must be investigated.
•	 Episodic	 ataxia	 –	 the	 efficacy	 of	 ace-
tazolamide (never established in a 
placebo-controlled trial) as well as the 
aminopyridines must be clarified.
•	 Phobic	postural	vertigo	–	the	potential	
efficacy of cognitive behavioral therapy 
and pharmacotherapy, for example 
with selective serotonin-reuptake inhi-
bitors, must be established.
•	 The	mechanisms	of	upbeat	and	down-
beat nystagmus, acquired pendular 
nystagmus, and other forms of nystag-
mus must be clarified.
•	 The	 anterior	 canal	 variant	 of	 benign	
paroxysmal positioning vertigo must 
also be elucidated, in order to evaluate 
diagnostic criteria, prevalence, and tre-
atment. There is an ongoing debate on 
whether this variant exists at all.
Further, histopathological post-mortem 
studies will require the establishment of brain 
banks on frequent disorders like bilateral 
between	 these	 different	 specialties.	 Such	
cooperation requires the establishment 
of specialized interdisciplinary centers, 
in which ENT specialists, neurologists, 
ophthalmologists, psychiatrists, psycholo-
gists, cardiologists, radiologists, and neu-
roradiologists closely collaborate and 
examine patients together as a team. An 
example of such a center is the newly estab-
lished Integrated Center for Research and 
Treatment of Vertigo, Dizziness and Ocular 
Motor Disorders (IFBLMU) at the University 
of	 Munich.	 The	 German	 Ministry	 of	
Research and Education will fund this 
center with 5 million Euros per year for 
5–10 years. This novel patient-centered 
approach will allow the establishment of 
new paradigms to overcome the boundaries 
between these disciplines and thus have an 
enduring effect.
Third, only such an interdisciplinary 
approach will increase the knowledge and 
improve the skills of medical students and 
even physicians experienced in this field. 
Interdisciplinary thinking will be impera-
tive in addition to a specialized curricu-
lum covering vertigo, dizziness, imbalance, 
ocular motor, and gait disorders. It would 
suffice to have just one or two such centers 
per country. This approach would also have 
a snowballing effect leading to the creation 
of special examinations and certificate of 
qualifications.
Fourth, diagnostic criteria for some of 
the vestibular and ocular motor disorders 
have to be better defined and then inter-
nationally	recognized.	The	Bárány	Society	
therefore recently proposed an initiative, 
led by Dr. Alexandre Bisdorff, to establish 
committees that would formulate such cri-
teria for the different forms of vertigo and 
dizziness. This has implications for clini-
cal practice as well as for further clinical 
trials.
Fifth, multicenter, multinational pro-
spective randomized placebo- controlled 
trials are urgently needed for a number of 
these	disorders.	Such	studies	should	also	
measure the quality of life and functioning 
whenever possible. Examples are:
